scispace - formally typeset
P

Peng Li

Researcher at Brigham and Women's Hospital

Publications -  260
Citations -  9262

Peng Li is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 39, co-authored 216 publications receiving 6746 citations. Previous affiliations of Peng Li include Memorial Hospital of South Bend & United States Department of Health and Human Services.

Papers
More filters
Journal ArticleDOI

A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium

Zhenqiang Su, +164 more
- 01 Sep 2014 - 
TL;DR: The complete SEQC data sets, comprising >100 billion reads, provide unique resources for evaluating RNA-seq analyses for clinical and regulatory settings, and measurement performance depends on the platform and data analysis pipeline, and variation is large for transcript-level profiling.
Journal ArticleDOI

Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages

TL;DR: IL-2 influences helper T cell differentiation by modulating the expression of cytokine receptors to help specify and maintain differentiated states.
Journal ArticleDOI

BATF–JUN is critical for IRF4-mediated transcription in T cells

TL;DR: It is revealed that IRf4 can signal via complexes containing ETS or AP1 motifs depending on the cellular context, thus indicating new approaches for modulating IRF4-dependent transcription.
Journal ArticleDOI

Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay.

TL;DR: A rapid and sensitive lateral flow immunoassay (LFIA) that uses lanthanide-doped polysterene nanoparticles (LNPs) to detect anti-SARV-CoV-2 IgG in human serum that can be useful for monitoring the progression COVID-19 and evaluating patients’ response to treatment.